[
  {
    "objectID": "quarto/index.html",
    "href": "quarto/index.html",
    "title": "Clinical Outcomes of NAFLD/NASH in HF-CKD-T2DM (With Propensity Score Matching)",
    "section": "",
    "text": "Data Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions with HF-CKD-T2DM.\nHF-CKD-T2DM + NAFLD/NASH Categories:\n\nHF-CKD-T2DM with NAFLD/NASH\nHF-CKD-T2DM without NAFLD/NASH\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nSoftware: All analyses were performed using R Version 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria)"
  },
  {
    "objectID": "quarto/index.html#preamble",
    "href": "quarto/index.html#preamble",
    "title": "Clinical Outcomes of NAFLD/NASH in HF-CKD-T2DM (With Propensity Score Matching)",
    "section": "",
    "text": "Data Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions with HF-CKD-T2DM.\nHF-CKD-T2DM + NAFLD/NASH Categories:\n\nHF-CKD-T2DM with NAFLD/NASH\nHF-CKD-T2DM without NAFLD/NASH\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nSoftware: All analyses were performed using R Version 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria)"
  },
  {
    "objectID": "quarto/index.html#baseline-table",
    "href": "quarto/index.html#baseline-table",
    "title": "Clinical Outcomes of NAFLD/NASH in HF-CKD-T2DM (With Propensity Score Matching)",
    "section": "Baseline Table:",
    "text": "Baseline Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nWith NAFLD/NASH\nN = 110\n1\nWithout NAFLD/NASH\nN = 110\n1\np-value\n2\n\n\n\n\nAge, y\n64 (13)\n64 (13)\n&gt;0.9\n\n\nSex\n\n\n\n\n0.7\n\n\n    Female\n75 (68%)\n70 (64%)\n\n\n\n\n    Male\n35 (32%)\n40 (36%)\n\n\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n75 (68%)\n80 (73%)\n\n\n\n\n    Asian or Pacific Islander\n0 (0%)\n0 (0%)\n\n\n\n\n    Black\n20 (18%)\n20 (18%)\n\n\n\n\n    Hispanic\n15 (14%)\n10 (9.1%)\n\n\n\n\n    Native American\n0 (0%)\n0 (0%)\n\n\n\n\n    Other\n0 (0%)\n0 (0%)\n\n\n\n\nElixhauser comorbidity index\n\n\n\n\n0.062\n\n\n    6\n0 (0%)\n5 (4.5%)\n\n\n\n\n    7\n25 (23%)\n15 (14%)\n\n\n\n\n    8\n30 (27%)\n15 (14%)\n\n\n\n\n    9\n15 (14%)\n25 (23%)\n\n\n\n\n    10\n10 (9.1%)\n40 (36%)\n\n\n\n\n    11\n10 (9.1%)\n0 (0%)\n\n\n\n\n    12\n20 (18%)\n0 (0%)\n\n\n\n\n    13\n0 (0%)\n10 (9.1%)\n\n\n\n\nResidential income\n\n\n\n\n0.4\n\n\n    $1 - $51,999\n35 (32%)\n45 (41%)\n\n\n\n\n    $52,000 - $65,999\n45 (41%)\n20 (18%)\n\n\n\n\n    $66,000 - $87,999\n10 (9.1%)\n25 (23%)\n\n\n\n\n    $88,000 or more\n20 (18%)\n20 (18%)\n\n\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n20 (18%)\n30 (27%)\n\n\n\n\n    Medicaid\n20 (18%)\n5 (4.5%)\n\n\n\n\n    Medicare\n70 (64%)\n75 (68%)\n\n\n\n\n    Other\n0 (0%)\n0 (0%)\n\n\n\n\nHospital region\n\n\n\n\n0.7\n\n\n    Midwest\n25 (23%)\n15 (14%)\n\n\n\n\n    Northeast\n10 (9.1%)\n5 (4.5%)\n\n\n\n\n    South\n60 (55%)\n75 (68%)\n\n\n\n\n    West\n15 (14%)\n15 (14%)\n\n\n\n\nHospital bedsize\n\n\n\n\n0.6\n\n\n    Large\n75 (68%)\n60 (55%)\n\n\n\n\n    Medium\n25 (23%)\n40 (36%)\n\n\n\n\n    Small\n10 (9.1%)\n10 (9.1%)\n\n\n\n\nHospital location and teaching status\n\n\n\n\n0.030\n\n\n    Rural\n15 (14%)\n0 (0%)\n\n\n\n\n    Urban, non-teaching\n10 (9.1%)\n45 (41%)\n\n\n\n\n    Urban, teaching\n85 (77%)\n65 (59%)\n\n\n\n\nHypertension\n\n\n\n\n\n\n\n\n    Yes\n110 (100%)\n110 (100%)\n\n\n\n\nHyperlipidemia\n75 (68%)\n75 (68%)\n&gt;0.9\n\n\nCoronary artery disease\n60 (55%)\n45 (41%)\n0.4\n\n\nPeripheral vascular disease\n5 (4.5%)\n25 (23%)\n0.10\n\n\nChronic obstructive pulmonary disease\n50 (45%)\n50 (45%)\n&gt;0.9\n\n\nDementia\n10 (9.1%)\n0 (0%)\n0.2\n\n\nObstructive sleep apnea\n40 (36%)\n40 (36%)\n&gt;0.9\n\n\nAlcohol use disorder\n15 (14%)\n45 (41%)\n0.066\n\n\nValvular heart disease\n5 (4.5%)\n20 (18%)\n0.2\n\n\nAtrial Fibrillation\n50 (45%)\n50 (45%)\n&gt;0.9\n\n\nCancer\n5 (4.5%)\n0 (0%)\n0.3\n\n\nSmoking\n\n\n\n\n\n\n\n\n    No\n110 (100%)\n110 (100%)\n\n\n\n\nObesity\n95 (86%)\n100 (91%)\n0.6\n\n\nIrritable bowel disease\n\n\n\n\n\n\n\n\n    No\n110 (100%)\n110 (100%)\n\n\n\n\n\n1\nMean (SD); n (%)\n\n\n2\nDesign-based KruskalWallis test; Pearson’s X^2: Rao & Scott adjustment"
  },
  {
    "objectID": "quarto/index.html#outcomes-table",
    "href": "quarto/index.html#outcomes-table",
    "title": "Clinical Outcomes of NAFLD/NASH in HF-CKD-T2DM (With Propensity Score Matching)",
    "section": "Outcomes Table:",
    "text": "Outcomes Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nWithout NAFLD/NASH\nN = 16,500\n1\nWith NAFLD/NASH\nN = 16,500\n1\np-value\n2\n\n\n\n\nDied during hospitalization\n970 (5.9%)\n530 (3.2%)\n&lt;0.001\n\n\nLength of stay (days)\n8.1 (7.8)\n7.0 (6.8)\n&lt;0.001\n\n\nInflation-adjusted total charge ($)\n99,302 (148,741)\n82,411 (98,863)\n0.003\n\n\n\n1\nn (%); Mean (SD)\n\n\n2\nPearson’s X^2: Rao & Scott adjustment; Design-based KruskalWallis test"
  },
  {
    "objectID": "quarto/index.html#multivariable-logistic-regression",
    "href": "quarto/index.html#multivariable-logistic-regression",
    "title": "Clinical Outcomes of NAFLD/NASH in HF-CKD-T2DM (With Propensity Score Matching)",
    "section": "Multivariable Logistic Regression:",
    "text": "Multivariable Logistic Regression:\n\nAll-Cause Mortality:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n1\n95% CI\n1\np-value\n\n\n\n\nCategories\n\n\n\n\n\n\n\n\n    Without NAFLD/NASH\n—\n—\n\n\n\n\n    With NAFLD/NASH\n0.50\n0.39, 0.65\n&lt;0.001\n\n\nAge, y\n1.01\n1.00, 1.03\n0.048\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.92\n0.71, 1.18\n0.5\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.15\n0.49, 2.72\n0.7\n\n\n    Black\n0.85\n0.59, 1.23\n0.4\n\n\n    Hispanic\n1.04\n0.68, 1.59\n0.9\n\n\n    Native American\n0.61\n0.07, 5.34\n0.7\n\n\n    Other\n0.61\n0.19, 1.93\n0.4\n\n\nElixhauser comorbidity index\n1.49\n1.38, 1.61\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n1.12\n0.82, 1.51\n0.5\n\n\n    $66,000 - $87,999\n1.01\n0.72, 1.41\n&gt;0.9\n\n\n    $88,000 or more\n1.52\n1.04, 2.22\n0.032\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.98\n0.62, 1.55\n&gt;0.9\n\n\n    Medicare\n0.73\n0.52, 1.03\n0.073\n\n\n    Other\n1.09\n0.46, 2.58\n0.8\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.77\n0.48, 1.22\n0.3\n\n\n    South\n0.83\n0.62, 1.13\n0.2\n\n\n    West\n0.74\n0.50, 1.10\n0.13\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.75\n0.56, 1.02\n0.068\n\n\n    Small\n0.94\n0.68, 1.30\n0.7\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.20\n0.71, 2.02\n0.5\n\n\n    Urban, teaching\n1.20\n0.75, 1.90\n0.4\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.34\n0.20, 0.60\n&lt;0.001\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.70\n0.54, 0.90\n0.006\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.96\n0.74, 1.25\n0.8\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.57\n0.40, 0.82\n0.002\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.55\n0.42, 0.72\n&lt;0.001\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.57\n0.29, 1.10\n0.10\n\n\nObstructive sleep apnea\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.65\n0.50, 0.86\n0.002\n\n\nAlcohol use disorder\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.96\n0.73, 1.26\n0.8\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.60\n0.44, 0.83\n0.002\n\n\nAtrial Fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.83\n0.64, 1.08\n0.2\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.02\n0.61, 1.69\n&gt;0.9\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.43\n0.31, 0.60\n&lt;0.001\n\n\nSmoking\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.94\n0.45, 8.39\n0.4\n\n\nIrritable bowel disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.00\n0.00, 0.00\n&lt;0.001\n\n\n\n1\nOR = Odds Ratio, CI = Confidence Interval"
  },
  {
    "objectID": "quarto/index.html#multivariable-linear-regression",
    "href": "quarto/index.html#multivariable-linear-regression",
    "title": "Clinical Outcomes of NAFLD/NASH in HF-CKD-T2DM (With Propensity Score Matching)",
    "section": "Multivariable Linear Regression:",
    "text": "Multivariable Linear Regression:\n\nLength of Stay:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\n1\np-value\n\n\n\n\nCategories\n\n\n\n\n\n\n\n\n    Without NAFLD/NASH\n—\n—\n\n\n\n\n    With NAFLD/NASH\n-1.1\n-1.5, -0.79\n&lt;0.001\n\n\nAge, y\n-0.01\n-0.03, 0.01\n0.4\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.35\n0.00, 0.70\n0.053\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n-0.95\n-2.3, 0.36\n0.2\n\n\n    Black\n0.52\n-0.04, 1.1\n0.068\n\n\n    Hispanic\n-0.33\n-0.90, 0.23\n0.3\n\n\n    Native American\n0.92\n-1.5, 3.3\n0.5\n\n\n    Other\n-0.36\n-1.4, 0.65\n0.5\n\n\nElixhauser comorbidity index\n1.1\n0.96, 1.3\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n-0.14\n-0.56, 0.29\n0.5\n\n\n    $66,000 - $87,999\n-0.13\n-0.62, 0.36\n0.6\n\n\n    $88,000 or more\n0.12\n-0.54, 0.78\n0.7\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n-0.02\n-0.85, 0.82\n&gt;0.9\n\n\n    Medicare\n-0.87\n-1.4, -0.36\n&lt;0.001\n\n\n    Other\n-1.1\n-2.2, -0.07\n0.036\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.42\n-0.19, 1.0\n0.2\n\n\n    South\n-0.03\n-0.48, 0.43\n&gt;0.9\n\n\n    West\n-1.4\n-2.0, -0.89\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-0.78\n-1.2, -0.38\n&lt;0.001\n\n\n    Small\n-1.2\n-1.7, -0.70\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.4\n0.75, 2.0\n&lt;0.001\n\n\n    Urban, teaching\n2.2\n1.6, 2.7\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1.5\n-2.7, -0.35\n0.011\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1.1\n-1.5, -0.67\n&lt;0.001\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.13\n-0.49, 0.23\n0.5\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1.3\n-1.8, -0.85\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1.5\n-2.0, -1.1\n&lt;0.001\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.42\n-0.50, 1.3\n0.4\n\n\nObstructive sleep apnea\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.55\n-0.91, -0.20\n0.002\n\n\nAlcohol use disorder\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1.3\n-1.7, -0.90\n&lt;0.001\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.80\n-1.3, -0.34\n&lt;0.001\n\n\nAtrial Fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.28\n-0.65, 0.09\n0.14\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1.3\n-2.1, -0.47\n0.002\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-2.7\n-3.4, -1.9\n&lt;0.001\n\n\nSmoking\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1.7\n-3.1, -0.18\n0.028\n\n\nIrritable bowel disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n3.3\n-1.6, 8.3\n0.2\n\n\n\n1\nCI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nInflation Adjusted Total Charge:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\n1\np-value\n\n\n\n\nCategories\n\n\n\n\n\n\n\n\n    Without NAFLD/NASH\n—\n—\n\n\n\n\n    With NAFLD/NASH\n-18,358\n-24,330, -12,386\n&lt;0.001\n\n\nAge, y\n-421\n-726, -116\n0.007\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n11,585\n5,112, 18,059\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n9,007\n-30,499, 48,513\n0.7\n\n\n    Black\n535\n-7,270, 8,340\n0.9\n\n\n    Hispanic\n8,263\n-2,182, 18,707\n0.12\n\n\n    Native American\n3,762\n-48,174, 55,697\n0.9\n\n\n    Other\n1,874\n-14,442, 18,190\n0.8\n\n\nElixhauser comorbidity index\n15,343\n12,725, 17,962\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n-1,416\n-8,789, 5,956\n0.7\n\n\n    $66,000 - $87,999\n-985\n-9,502, 7,532\n0.8\n\n\n    $88,000 or more\n912\n-9,610, 11,434\n0.9\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n-15,654\n-28,845, -2,462\n0.020\n\n\n    Medicare\n-14,888\n-24,847, -4,930\n0.003\n\n\n    Other\n-4,442\n-28,333, 19,450\n0.7\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n9,919\n-448, 20,286\n0.061\n\n\n    South\n12,258\n5,049, 19,466\n&lt;0.001\n\n\n    West\n33,677\n20,132, 47,221\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-15,320\n-22,686, -7,954\n&lt;0.001\n\n\n    Small\n-21,607\n-30,248, -12,965\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n28,835\n19,822, 37,849\n&lt;0.001\n\n\n    Urban, teaching\n42,537\n34,837, 50,237\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-12,755\n-30,369, 4,859\n0.2\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-10,133\n-16,855, -3,411\n0.003\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n6,717\n886, 12,548\n0.024\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-18,226\n-26,629, -9,823\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-21,700\n-28,022, -15,379\n&lt;0.001\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-13,430\n-25,568, -1,292\n0.030\n\n\nObstructive sleep apnea\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-11,592\n-17,578, -5,606\n&lt;0.001\n\n\nAlcohol use disorder\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-11,741\n-19,185, -4,298\n0.002\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-5,267\n-13,465, 2,931\n0.2\n\n\nAtrial Fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2,789\n-3,765, 9,343\n0.4\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-21,748\n-34,354, -9,142\n&lt;0.001\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-32,666\n-48,892, -16,440\n&lt;0.001\n\n\nSmoking\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-23,098\n-57,534, 11,338\n0.2\n\n\nIrritable bowel disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n46,517\n-40,233, 133,267\n0.3\n\n\n\n1\nCI = Confidence Interval"
  }
]